Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative analgesia after lower extremity surgery using different fascia iliaca compartment block volumes
ACTRN12616000892415Phase 4Completed
- Sponsor
- metin KILINC
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bupivacaine in postoperative pain (3 arms), sponsored by metin KILINC. Primary endpoint: Postoperative pain intensity. Started Dec 2013; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12616000892415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000892415.